Medistim ASA (LON:0OCD)

Medistim ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	103.83	103.82	113.97	90.9	69.39
Depreciation & Amortization	24.51	23.66	23.29	23.43	16.25
Other Amortization	-	-	-	-	6.89
Other Operating Activities	2.01	5.69	12.91	9.83	3.17
Change in Accounts Receivable	5.32	27.35	-33.02	-11.15	4.7
Change in Inventory	-15.13	-31.06	-16.92	15.25	-22.6
Change in Accounts Payable	1.95	0.61	11.27	-0.32	-1.3
Change in Other Net Operating Assets	20.61	-10.88	2	-0.57	-2.38
Operating Cash Flow	143.1	119.2	113.49	127.37	74.13
Operating Cash Flow Growth	20.06%	5.03%	-10.90%	71.82%	-7.77%
Capital Expenditures	-6.07	-16.4	-9.25	-7.4	-7.45
Sale (Purchase) of Intangibles	-18.63	-13.33	-11.85	-4.08	-3.19
Investing Cash Flow	-24.69	-29.73	-21.1	-11.49	-10.64
Long-Term Debt Repaid	-9.12	-8.71	-7.31	-12	-9.68
Net Debt Issued (Repaid)	-9.12	-8.71	-7.31	-12	-9.68
Common Dividends Paid	-82.41	-82.18	-68.4	-54.64	-50.05
Other Financing Activities	-	-	5.4	7.59	1.39
Financing Cash Flow	-91.53	-90.89	-70.3	-59.05	-58.35
Foreign Exchange Rate Adjustments	-1.54	2.65	1.07	0.76	-
Net Cash Flow	25.34	1.23	23.15	57.6	5.15
Free Cash Flow	137.04	102.8	104.24	119.97	66.68
Free Cash Flow Growth	33.30%	-1.38%	-13.11%	79.91%	-0.02%
Free Cash Flow Margin	24.64%	19.73%	21.44%	28.71%	18.72%
Free Cash Flow Per Share	7.48	5.62	5.70	6.57	3.66
Cash Income Tax Paid	28.4	25.7	19.17	13.34	19.05
Levered Free Cash Flow	81.67	64.81	56.39	98.98	47.3
Unlevered Free Cash Flow	81.67	64.81	56.47	99.09	47.4
Change in Net Working Capital	0.07	11.28	34	-17.78	24.78

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.